1. Home
  2. CHMI vs SKYE Comparison

CHMI vs SKYE Comparison

Compare CHMI & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHMI
  • SKYE
  • Stock Information
  • Founded
  • CHMI 2012
  • SKYE 2012
  • Country
  • CHMI United States
  • SKYE United States
  • Employees
  • CHMI N/A
  • SKYE N/A
  • Industry
  • CHMI Real Estate Investment Trusts
  • SKYE Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHMI Real Estate
  • SKYE Health Care
  • Exchange
  • CHMI Nasdaq
  • SKYE Nasdaq
  • Market Cap
  • CHMI 92.0M
  • SKYE 80.7M
  • IPO Year
  • CHMI 2013
  • SKYE N/A
  • Fundamental
  • Price
  • CHMI $3.39
  • SKYE $3.14
  • Analyst Decision
  • CHMI Buy
  • SKYE Buy
  • Analyst Count
  • CHMI 3
  • SKYE 6
  • Target Price
  • CHMI $5.00
  • SKYE $18.67
  • AVG Volume (30 Days)
  • CHMI 250.4K
  • SKYE 173.0K
  • Earning Date
  • CHMI 03-06-2025
  • SKYE 02-13-2025
  • Dividend Yield
  • CHMI 17.65%
  • SKYE N/A
  • EPS Growth
  • CHMI N/A
  • SKYE N/A
  • EPS
  • CHMI N/A
  • SKYE N/A
  • Revenue
  • CHMI N/A
  • SKYE N/A
  • Revenue This Year
  • CHMI N/A
  • SKYE N/A
  • Revenue Next Year
  • CHMI $27.78
  • SKYE N/A
  • P/E Ratio
  • CHMI N/A
  • SKYE N/A
  • Revenue Growth
  • CHMI N/A
  • SKYE N/A
  • 52 Week Low
  • CHMI $2.50
  • SKYE $2.31
  • 52 Week High
  • CHMI $3.99
  • SKYE $19.41
  • Technical
  • Relative Strength Index (RSI)
  • CHMI 71.05
  • SKYE 52.82
  • Support Level
  • CHMI $3.07
  • SKYE $2.70
  • Resistance Level
  • CHMI $3.52
  • SKYE $3.29
  • Average True Range (ATR)
  • CHMI 0.09
  • SKYE 0.45
  • MACD
  • CHMI 0.03
  • SKYE 0.05
  • Stochastic Oscillator
  • CHMI 78.95
  • SKYE 41.27

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About SKYE Skye Bioscience Inc. Common Stock

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: